The Lancet in conversation with

The Lancet in conversation with

By The Lancet GroupMedicineHealth & Fitness
Download on the App Store

The Lancet in conversation with episodes

  • Gene therapy for retinal dystrophy: The Lancet: January 5, 2018

    Rebecca Cooney discusses the newly FDA-approved gene therapy for treating loss of vision as a result of retinal dystrophy.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    9 min
  • You don't know me: The Lancet: December 23, 2017

    The author of the Wakley Prize-winning essay, Kate Rowland, talks about the ethics of care and the philosophy underlying the clinician-patient relationship, themes raised in her essay.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    15 min
  • Public availability of trial protocols: The Lancet: December 16, 2017

    Joan Marsh and Paul Glasziou discuss what steps can be taken to reduce research waste with the public availability of trial protocols.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    7 min
  • Weight management in type 2 diabetes: The Lancet: December 5, 2017

    Roy Taylor talks about weight management techniques and remission in type 2 diabetes.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    9 min
  • Liver disease: The Lancet: November 29, 2017

    Martin McKee discusses the final report of the Lancet's Commission on liver disease, highlighting the health costs of excess alcohol consumption, obesity, and viral hepatitis.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    12 min
  • Heart failure incidence: The Lancet: November 21, 2017

    Kazem Rahimi discusses the temporal trends and patterns in heart failure incidence in the UK between 2002 and 2014. 

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    8 min
  • Lancet Countdown 2017: The Lancet: October 30, 2017

    Nick Watts and Elizabeth Robinson discuss their findings from the 2017 report of The Lancet Countdown: Tracking Progress on Health and Climate Change

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    22 min
  • Conflict in Colombia: The Lancet: October 26, 2017

    Joe Parkin Daniels, author of a new World Report on a military hospital in Bogota, joins us to discuss the nuances of peace and conflict in Colombia since the FARC peace deal, and the challenges still facing healthcare in the country.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    14 min
  • The Lancet Commission on Pollution and Health: October 19, 2017

    Gina McCarthy, former EPA Administrator, and Commission leads Philip Landrigan and Richard Fuller join Gavin Cleaver for a discussion of the problems of pollution and the solutions available.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    28 min
  • Palliative Care and Pain Relief: The Lancet: October 12, 2017

    Felicia Knaul and Julio Frenk discuss the Commission on the global access to palliative care and pain relief, highlighting the new metric used to measure the burden, an essential package to these treatments, and integration of palliative care and pain relief into health systems.

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    41 min

About The Lancet in conversation with

From the publisher's feed

Niall Boyce, Chloe Wilson, and Callum Davidson—editors at The Lancet— in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and…

More shows like The Lancet in conversation with

JAMA Editors' Summary by JAMA Network

JAMA Editors' Summary

136 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

21 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

News Connect あなたと経済をつなぐ5分間 #ニュースコネクト by Chronicle

News Connect あなたと経済をつなぐ5分間 #ニュースコネクト

20 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health Western Pacific in conversation with by The Lancet Group

The Lancet Regional Health Western Pacific in conversation with

0 Listeners

The Lancet Primary Care in conversation with by The Lancet Group

The Lancet Primary Care in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners